New Delhi, Delhi, India, Thursday, December 13, 2012 – (Business Wire India)
Nova IVI Fertility, a division of Nova Medical Centers Pvt Ltd, India’s leading short stay surgical company announces the launch of New Delhi’s first of its kind IVF center with embryoscope facility, a technology to monitor growth of embryos with real time videos and live updates. Representing a world-class facility and spread across 12,500 sq feet, the hospital is located in the heart of the city and accessible to all patients. Nova IVI Fertility’s other centers are in Ahmedabad, Bangalore, Kolkata and Mumbai with centers in Chennai and other cities to open soon.
Speaking on the occasion, Mr. Suresh Soni, Chairman and CEO of Nova Medical Centers commented, “We have aggressive expansion plans for Nova IVI Fertility Delhi, and are extremely pleased to announce our foray into this city. We are also delighted to welcome Dr. Nalini Mahajan who brings commendable experience and expertise in ART treatment. Dr. Mahajan will serve as the Clinical Director of Nova IVI Fertility-Delhi. The center is dedicated to helping couples by offering a comprehensive range of treatments at an affordable price. With five well-established fertility centers in major cities, Nova IVI Fertility plans to launch as many as 20 centers in the next two years with the goal of bringing high quality assisted reproductive therapy to the people of India.”
Nova IVI Fertility is a partnership between Nova Pulse IVF and IVI, Spain. Founded in Valencia, Spain in 1990, IVI is the world leader in reproductive medicine with 23 clinics spread across Europe and South America. Nova takes the best fertility physicians in India and, under the guidance of the world-leaders in infertility therapy, bring standardized, high-quality assisted reproductive technology to its patients delivering results matching international standards. Nova focuses on providing this care in the most cost-effective, transparent and ethical manner possible.
On the occasion, Dr. Nalini Mahajan, the center’s senior consultant and clinical coordinator said, “Nova IVI fertility centers aim to revolutionize fertility services in the country. We believe in providing efficiency, technological excellence, and the highest code of ethics combined with compassion. We lay great emphasis on the general well-being of the couple and our counselors and nutritionists are fully involved in the treatment from the very beginning. We have designed economy packages to provide assisted reproductive technology services to a larger section of the population. Our collaboration with IVI Spain – world leaders in IVF research and technology, allows us to be the first to offer the most recent techniques to improve pregnancy rates. At Nova IVI Fertility we will always endeavor to provide the best to our patients.”
Infertility is an increasingly prevalent health concern and treatments are widely being sought. However, there is a widespread shortage of standardized clinical protocols, structured training, quality laboratories and ethical practices. Nova IVI Fertility’s goal is to address this urgent need for an organized institutional provider for fertility treatment. With the rising prevalence of fertility tourism, Delhi, the capital of India, is a much-needed addition to Nova IVI Fertility’s sought after medical facilities.
Nova IVI Fertility Delhi is situated at B2/1A, Safdarjung Enclave, Africa Avenue. It is conveniently located and easily accessible from the airport and central parts of Delhi. The center will provide both advanced technology and expert medical care. This is Nova IVI Fertility’s first center in North India and in addition to providing the core procedures such as IUI, IVF, and andrology services and embryoscope, they also offer several state-of-the-art technologies such as assisted hatching, blastocyst culture, and vitrification, a new method for preserving eggs and embryos. This center will also offer another sought after advanced technique known as IMSI (intracytoplasmic morphologically-selected sperm injection). This is an upgrade of ICSI (intracytoplasmic sperm injection), where the embryologist carries out the fertilization of the oocytes (egg) using an extremely high-powered microscope to select the sperm cells with the best morphological quality.
About Nova IVI Fertility:
Nova IVI Fertility is a joint venture between Nova Pulse IVF, a division of Nova Medical Centers – India’s leader in specialty outpatient care and IVI Spain- the global leader in reproductive medicine. This joint venture has resulted in the delivery of the best in class infertility treatment in India. Today, Nova IVI Fertility has to its credit, 3000 IVF babies and a success rate of 90% in single pregnancies. Nova IVI Fertility has well established satellite facilities in all the major cities in India with world-class amenities, latest in-house technologies and an internationally-acclaimed team of consultants. With over 18 years’ experience and a renowned team of over 250 gynaecologists and biologists worldwide as part of the IVI Group it has achieved the best pregnancy/patient ratio. Having the largest number of scientific publications and investments in R+D+I in order to translate improved methods into better results Nova has made commendable developments in Indian Healthcare within two years of starting operations, and thus hopes to live up to Nova’s vision of being the foremost infertility treatment center.
For further information, please visit www.novaivifertility.com.
To view the photograph, please click on the link given below:
From Left to Right: Dr.Nalini Mahajan-Director, Nova IVI Fertility, Delhi; Suresh Soni, Chairman and CEO, Member, Board of Directors (Nova IVI Fertility); Dr. Juan Antonio Garcia Velasco- Member, Board of Directors (Nova IVI Fertility) and Director of IVI- Madrid; Dr. Manish Banker – Medical Director, Member, Board of Directors (Nova IVI Fertility)
For picture(s)/data to illustrate this release click below:
http://www.BusinessWireIndia.com/attachments/1(251).jpg
>From Left to Right: Dr.Nalini Mahajan-Director, Nova IVI Fertility, Delhi; Suresh Soni, Chairman and CEO, Member, Board of Directors (Nova IVI Fertility); Dr. Juan Antonio Garcia Velasco- Member, Board of Directors (Nova IVI Fertility) and Director of IVI- Madrid; Dr. Manish Banker – Medical Director, Member, Board of Directors (Nova IVI Fertility)
CONTACT DETAILS
Arneeta Vasudeva, IPAN Hill+Knowlton Strategies, +91 9910019764, arneeta.vasudeva@hkstrategies.com
KEYWORDS
CONSUMER, BUSINESS SERVICES, HEALTHCARE, HEALTHCARE
If you wish to change your Business Wire India selection please click on this link http://www.businesswireindia.com/media/news.asp and use your personal username and password to login.
Submit your press release at http://www.businesswireindia.com
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…